SUBSCRIBERS

Corporate digest

Published Tue, Mar 17, 2020 · 09:50 PM

Singapore eDevelopment

CATALIST-LISTED Singapore eDevelopment (SeD) on Tuesday said its US subsidiary, Impact BioMedical, has tested two compounds that can successfully inhibit infection by the Covid-19 virus. Results from Impact BioMedical's recent molecular-docking studies indicate that compounds Linebacker and Equivir are able to block three integral viral mechanisms for Sars-CoV-2 (the virus behind Covid-19) replication and infection, said SeD.

IREIT Global

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes